Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03291626 · ClinicalTrials.gov registry record
Postoperative Delirium: EEG Markers of Sleep and Wakefulness
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 234
- Enrollment target
NCT03291626: Completed study, sponsored by Washington University School of Medicine.
NCT03291626 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 234 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03291626 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 234 participants
- Enrollment target
Study Summary
Postoperative delirium is a condition in which patients develop temporary difficulties in maintaining attention and thinking clearly. These new problems can appear after surgery and change throughout the day. This confusion can last several days. The overall purpose of this study is to measure brain activity during sleep and wakefulness to learn about their relationships to delirium after surgery. While participants may not feel like their normal self during the study, they are in the best position to help us learn how to improve the recovery of brain function and sleep in others having surgery. The investigators need to learn from those who have and have not become confused after their surgical procedure.
Primary Outcome
Awake EEG recorded at baseline, sleep EEG using Sleep Profiler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2024-11-28 |
What the finished NCT03291626 record still lists
NCT03291626 is an observational study that tracks outcomes without assigning an intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03291626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03291626 about?
NCT03291626 is a clinical study titled "Postoperative Delirium: EEG Markers of Sleep and Wakefulness". Postoperative delirium is a condition in which patients develop temporary difficulties in maintaining attention and thinking clearly. These new problems can appear after surgery and change throughout the day. This confusion can last several days. The overall purpose of this study is to measure brai...
What is the current status of trial NCT03291626?
This trial is currently completed. The enrollment target is 234 participants. The study started on 2018-10-16. Estimated completion is 2024-11-28.
Who is sponsoring clinical trial NCT03291626?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI